Abstract:<span class="a-plus-plus abstract-section id-a-sec1"><h3 class="a-plus-plus">Background</h3><p class="a-plus-plus">In recent studies, a 5-stage cardiac damage classification in severe aortic stenosis (AS) based on echocardiographic parameters has shown to provide predictive value regarding clinical outcome. The objective of this study was to investigate the prognostic impact of a cardiac damage classification based on invasive hemodynamics in patients with AS undergoing transcatheter aortic valve replacement (TAVR).</p></span><span class="a-plus-plus abstract-section id-a-sec2"><h3 class="a-plus-plus">Methods</h3><p class="a-plus-plus">A total of 1400 patients with symptomatic AS and full invasive hemodynamic assessment before TAVR were included. Patients were categorized according to their cardiac damage stage into five groups that are defined as: stage 0, no cardiac damage; stage 1, left ventricular damage; stage 2, left atrial and/or mitral valve damage; stage 3, pulmonary vasculature and/or tricuspid valve damage; stage 4, right ventricular damage.</p></span><span class="a-plus-plus abstract-section id-a-sec3"><h3 class="a-plus-plus">Results</h3><p class="a-plus-plus">9.9% patients were classified as stage 0, 23.6% as stage 1, the majority of patients as stage 2 (33.5%), 23.1% as stage 3 and 10% as stage 4. One- and 4-year mortality were 10.1%/29.5% in stage 0, 16.1%/60.6% in stage 1, 17.3%/39.4% in stage 2, 22%/54.6% in stage 3, 27.1%/62.2% in stage 4 (<em class="a-plus-plus">p</em> = 0.001/<em class="a-plus-plus">p</em> < 0.001). The extent of cardiac damage was independently associated with increased mortality after TAVR (HR 1.16 per each increment in stage, 95% confidence interval 1.03–1.18; <em class="a-plus-plus">p</em> = 0.018).</p></span><span class="a-plus-plus abstract-section id-a-sec4"><h3 class="a-plus-plus">Conclusions</h3><p class="a-plus-plus">Cardiac damage staging in severe AS patients based on invasive hemodynamics appears to show strong association between the extent of cardiac damage and post-TAVR mortality. This staging classification provides predictive value and may improve risk stratification, therapy management and decision-making in patients with AS.</p></span><span class="a-plus-plus abstract-section id-a-sec5 outputmedium-all"><h3 class="a-plus-plus">Graphic abstract</h3><p class="a-plus-plus"><span class="a-plus-plus figure category-standard float-no id-figa"><caption class="a-plus-plus caption language-en lang-en"><em class="a-plus-plus caption-content"> Invasive Staging Classification of Cardiac Damage in Severe Symptomatic Aortic Stenosis has an Impact on Outcome after TAVR. (Top) Invasive staging criteria for cardiac damage in five stages using left ventricular end-diastolic pressure (LVEDP) for stage 1 (red), post-capillary wedge pressure (PCWP) for stage 2 (green), systolic pulmonary artery pressure (SPAP) for stage 3 (purple) and right atrial pressure (RAP) for stage 4 (yellow). The cake chart shows the distribution of the different stage in the whole cohort. (Bottom) Survival Analyses According to Stage of Cardiac Damage after Transcatheter Aortic Valve Replacement using Invasive Criteria. Kaplan-Meier plots comparing overall (left) and cardiovascular (right) 4-year survival showing with the more advancing stage a higher mortality rate </em></caption></span></p></span>

Prognostic value of extraaortic‐valvular cardiac damage in patients with moderate aortic stenosis and reduced left ventricular ejection fraction

Mid-term prognostic value of the novel staging of cardiac damage in asymptomatic patients with moderate to severe aortic stenosis

Cardiac damage predicts the outcome of calcific aortic valve disease regardless of the severity of aortic stenosis

Cardiac Damage Staging Predicts Outcomes in Aortic Valve Stenosis After Aortic Valve Replacement: Meta-Analysis

The impact of extra-valvular cardiac damage on mid-term clinical outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis

Cardiac Damage in Early Aortic Stenosis: Is the Valve to Blame?

Outcomes of patients with calcific aortic valve disease according to the extent of cardiac damage

Outcome of aortic stenosis according to invasive cardiac damage staging after transcatheter aortic valve replacement

Impact of Early Changes in Cardiac Damage Following Transcatheter Aortic Valve Implantation.

Incremental Value of Biventricular Strain in Patients with Severe Aortic Stenosis

Symptoms development overtime according to the imaging based cardiac damage staging classification in asymptomatic patients with moderate to severe aortic stenosis

Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population

Risk of supranormal left ventricular ejection fraction in patients with aortic stenosis

Computed tomography-derived myocardial extracellular volume as a prognosis predictor in patients with severe aortic stenosis

Predictors of outcome in patients with moderate mixed aortic valve disease

Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long‐Term Registry

Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis

Early evolution of cardiac damage staging following transcatheter aortic valve replacement: prevalence, clinical patterns and prognostic significance

Staging Extramitral Cardiac Damage in Mitral Annular Calcification With Mitral Valve Dysfunction

Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction

Combined assessment of coronary microvascular dysfunction and left ventricular diastolic dysfunction can stratify prognosis of patients with nonobstructive coronary artery disease